You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

Displaying 202341 - 202350 of 207725 results
  1. Validation of a rapid point-of-care breath test for breast cancer

    SBC: MENSSANA RESEARCH INC            Topic: NCI

    DESCRIPTIONprovided by applicantThe clinical problemBreast cancer is the commonest cancer in womenin whom it is second only to lung cancer as a cause of cancer deathMammography is the mainstay of screening for breast cancerthough its value is limited by its large number of false positive and false negative findingsA new solution the problemThe combination of two diagnostic tests with different bio ...

    SBIR Phase II 2016 Department of Health and Human ServicesNational Institutes of Health
  2. Validation of a Rapid Progestin-Based Endocrine Disruption Screening Assay

    SBC: Fort Environmental Laboratories, Inc.            Topic: N/A

    Fort Environmental Laboratories, Inc.'s Phase I research project resulted in the development and standardization of an assay that tests substances that might disturb reproductive and developmental processes in animals by interfering with the endocrine system. The primary goal of the proposed research was to validate and commercialize the Xenopus laevis oocyte maturation germinal vesicle breakdown ...

    SBIR Phase I 2002 Environmental Protection Agency
  3. Validation of a Rapid Progestin-Based Endocrine Disruption Screening Assay

    SBC: Fort Environmental Laboratories, Inc.            Topic: N/A

    Fort Environmental Laboratories, Inc.'s Phase I research project resulted in the development and standardization of an assay that tests substances that might disturb reproductive and developmental processes in animals by interfering with the endocrine system. The primary goal of the proposed research was to validate and commercialize the Xenopus laevis oocyte maturation germinal vesicle breakdown ...

    SBIR Phase II 2002 Environmental Protection Agency
  4. Validation of a Rapid Progestin-Based Endocrine Disruption Screening Assay

    SBC: Fort Environmental Laboratories, Inc.            Topic: N/A

    Fort Environmental Laboratories, Inc.¿s Phase I research project resulted in the development and standardization of an assay that tests substances that might disturb reproductive and developmental processes in animals by interfering with the endocrine system. The primary goal of the proposed research was to validate and commercialize the Xenopus laevis oocyte maturation germinal vesicle breakdow ...

    SBIR Phase I 2002 Environmental Protection Agency
  5. Validation of a Rapid Progestin-Based Endocrine Disruption Screening Assay

    SBC: Fort Environmental Laboratories, Inc.            Topic: N/A

    Fort Environmental Laboratories, Inc.¿s Phase I research project resulted in the development and standardization of an assay that tests substances that might disturb reproductive and developmental processes in animals by interfering with the endocrine system. The primary goal of the proposed research was to validate and commercialize the Xenopus laevis oocyte maturation germinal vesicle breakdow ...

    SBIR Phase II 2003 Environmental Protection Agency
  6. Validation of a Rodent Mutagenicity Assay

    SBC: Litron Laboratories Ltd            Topic: NIEHS

    DESCRIPTION (provided by applicant): Mutation to DNA is a primary mechanism by which cancers arise. These events have also been implicated in diseases such as atherosclerosis, and processes such as aging. Therefore, there is an important need for sensitive analytical methods that facilitate the study of mutagenesis, as well as the identification of chemical or physical agents that can mutate DNA. ...

    SBIR Phase I 2010 Department of Health and Human ServicesNational Institutes of Health
  7. Validation of a Rodent Mutagenicity Assay

    SBC: Litron Laboratories Ltd            Topic: NIEHS

    DESCRIPTION (provided by applicant): Mutation to DNA is a primary mechanism by which cancers arise. These events have also been implicated in diseases such as atherosclerosis, and processes such as aging. Therefore, there is an important need for sensitiveanalytical methods that facilitate the study of mutagenesis, as well as the identification of chemical or physical agents that can mutate DNA. M ...

    SBIR Phase II 2011 Department of Health and Human ServicesNational Institutes of Health
  8. Validation of a RSK-inhibitor as a Novel Therapeutic for

    SBC: LUNA INNOVATIONS INCORPORATED            Topic: N/A

    DESCRIPTION (provided by applicant): The inactivation of the host immune response by Yersinia, the causative agent of the plague, is mediated by a family of six proteins called Yersinia outer proteins, or Yops, namely YopE, YopH, YopO, YopM, YopJ, and YopT. While the mechanisms of action of YopE, YopH, YopO, YopJ, and YopT are fairly well understood, the effects of YopM on the host response to Yer ...

    SBIR Phase I 2005 Department of Health and Human ServicesNational Institutes of Health
  9. Validation of artificial intelligence (AI) based software as medical device (SaMD) for retinopathy of prematurity (ROP)

    SBC: Siloam Vision, Inc.            Topic: NEI

    The purpose of this application is to perform the necessary clinical studies to seek regulatory approval for an artificial intelligence (AI) software as medical device (SaMD) for retinopathy of prematurity (ROP) diagnosis. ROP is a leading cause of childhood blindness worldwide, with approximately 50,000 babies going blind annually, most of which is preventable with accurate and timely diagnosis. ...

    SBIR Phase II 2023 Department of Health and Human ServicesNational Institutes of Health
  10. 5- Validation of Artificial Intelligence Technologies (VAIT)

    SBC: R-DEX SYSTEMS, INC.            Topic: N193A01

    As artificial intelligence (AI) becomes more ubiquitous in society and the DoD enterprise, trust in the results provided by AI is of paramount importance. To that end, R-DEX Systems introduces VAIT (Validation of Artificial Intelligence Technologies), a processing suite for assessing AI algorithms for validation, trust in the decision-making process, and robustness against adversarial attack. VAIT ...

    SBIR Phase I 2020 Department of DefenseNavy
US Flag An Official Website of the United States Government